A Structured Approach to Evaluating Life-Course Hypotheses: Moving Beyond Analyses of Exposed Versus Unexposed in the -Omics Context.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 16 10 2019
revised: 27 10 2020
accepted: 28 10 2020
pubmed: 31 10 2020
medline: 29 6 2021
entrez: 30 10 2020
Statut: ppublish

Résumé

The structured life-course modeling approach (SLCMA) is a theory-driven analytical method that empirically compares multiple prespecified life-course hypotheses characterizing time-dependent exposure-outcome relationships to determine which theory best fits the observed data. In this study, we performed simulations and empirical analyses to evaluate the performance of the SLCMA when applied to genomewide DNA methylation (DNAm). Using simulations (n = 700), we compared 5 statistical inference tests used with SLCMA, assessing the familywise error rate, statistical power, and confidence interval coverage to determine whether inference based on these tests was valid in the presence of substantial multiple testing and small effects-2 hallmark challenges of inference from -omics data. In the empirical analyses (n = 703), we evaluated the time-dependent relationship between childhood abuse and genomewide DNAm. In simulations, selective inference and the max-|t|-test performed best: Both controlled the familywise error rate and yielded moderate statistical power. Empirical analyses using SLCMA revealed time-dependent effects of childhood abuse on DNAm. Our findings show that SLCMA, applied and interpreted appropriately, can be used in high-throughput settings to examine time-dependent effects underlying exposure-outcome relationships over the life course. We provide recommendations for applying the SLCMA in -omics settings and encourage researchers to move beyond analyses of exposed versus unexposed individuals.

Identifiants

pubmed: 33125040
pii: 5943467
doi: 10.1093/aje/kwaa246
pmc: PMC8316613
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1101-1112

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH113930
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Genet Epidemiol. 2019 Apr;43(3):242-249
pubmed: 30659680
Int J Epidemiol. 2018 Oct 1;47(5):1623-1635
pubmed: 29912384
Int J Epidemiol. 2015 Aug;44(4):1288-304
pubmed: 25855720
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Int J Cancer. 2019 Jan 1;144(1):59-67
pubmed: 29981162
Am J Epidemiol. 2006 Jan 1;163(1):84-96
pubmed: 16306313
Curr Environ Health Rep. 2018 Sep;5(3):328-337
pubmed: 30054820
Ann Rheum Dis. 2012 May;71(5):655-60
pubmed: 21979003
Am J Epidemiol. 2014 May 15;179(10):1197-207
pubmed: 24722997
J Child Psychol Psychiatry. 2018 Aug;59(8):845-854
pubmed: 29512866
Stat Med. 2019 May 20;38(11):2074-2102
pubmed: 30652356
Am J Epidemiol. 2014 Jul 15;180(2):127-8
pubmed: 24966223
Ann Stat. 2014 Apr;42(2):413-468
pubmed: 25574062
Am J Hum Genet. 2017 Jul 6;101(1):5-22
pubmed: 28686856
Int J Epidemiol. 2016 Aug;45(4):1280-1294
pubmed: 27681097
Nature. 2019 Mar;567(7748):305-307
pubmed: 30894741
Am J Epidemiol. 2016 Oct 1;184(7):520-531
pubmed: 27651384
Am J Epidemiol. 2018 Nov 1;187(11):2346-2354
pubmed: 30060108
Am J Epidemiol. 2015 Dec 15;182(12):977-9
pubmed: 26628513
Epidemiology. 2015 Sep;26(5):719-26
pubmed: 26172863
Int J Epidemiol. 2015 May 13;44(4):1429-1441
pubmed: 25972603
Int J Epidemiol. 2016 Aug;45(4):973-988
pubmed: 27880685
Am J Prev Med. 2011 Oct;41(4):376-84
pubmed: 21961464
Int J Epidemiol. 2002 Apr;31(2):285-93
pubmed: 11980781
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886
pubmed: 28108528
Nat Genet. 2019 Feb;51(2):343-353
pubmed: 30692680
Psychol Med. 2018 Nov;48(15):2562-2572
pubmed: 29478418
Bioinformatics. 2016 Mar 15;32(6):850-8
pubmed: 26576654
Biol Psychiatry. 2019 May 15;85(10):838-849
pubmed: 30905381
Am J Epidemiol. 2019 May 1;188(5):890-895
pubmed: 30877293
Hum Mol Genet. 2015 Apr 15;24(8):2201-17
pubmed: 25552657
J Child Psychol Psychiatry. 2012 Jun;53(6):632-40
pubmed: 22211468
Int J Epidemiol. 2016 Aug;45(4):1271-1279
pubmed: 27371628
Int J Epidemiol. 2009 Apr;38(2):528-37
pubmed: 19028777
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH